Getting the message across: mechanisms of physiological cross talk by adipose tissue (Q37405747)

20 August 2017

1 reference

title

Getting the message across: mechanisms of physiological cross talk by adipose tissue (English)

1 reference

20 August 2017

Do-Eun Lee

1

1 reference

20 August 2017

Sylvia Kehlenbrink

2

1 reference

20 August 2017

Hanna Lee

3

1 reference

20 August 2017

Meredith Hawkins

4

1 reference

20 August 2017

John S Yudkin

5

1 reference

20 August 2017

3 March 2009

1 reference

American Journal of Physiology - Endocrinology and Metabolism

20 August 2017

1 reference

20 August 2017

296

1 reference

20 August 2017

E1210-29

1 reference

20 August 2017

6

1 reference

Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver

20 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Metabolic actions of adipocyte hormones: focus on adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Stimulation of phosphoenolpyruvate carboxykinase gene expression by fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

IKK-beta links inflammation to obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Protein kinase C theta activation induces insulin-mediated constriction of muscle resistance arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Salicylates as hypoglycemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Why visceral fat is bad: mechanisms of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titrati

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Apelin, a newly identified adipokine up-regulated by insulin and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Epidemiology, trends, and morbidities of obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Role of brain insulin receptor in control of body weight and reproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Social inequality in coronary risk: Central obesity and the metabolic syndrome. Evidence from the Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Does central obesity reflect "Cushing's disease of the omentum"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

IKKbeta/NF-kappaB activation causes severe muscle wasting in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Role of inflammation in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Role of adiponectin in human skeletal muscle bioenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Acid-sensing ion channel 3 (ASIC3) cell surface expression is modulated by PSD-95 within lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Caloric restriction, body fat and ageing in experimental models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Direct innervation of white fat and adrenal medullary catecholamines mediate photoperiodic changes in body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Bone marrow plasminogen activator inhibitor-1 influences the development of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Apelin stimulates glucose utilization in normal and obese insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Reduced access to insulin-sensitive tissues in dogs with obesity secondary to increased fat intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Leptin regulates striatal regions and human eating behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Increased oxidative stress in obesity and its impact on metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Circulating mononuclear cells in the obese are in a proinflammatory state

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Sirtuins as potential targets for metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Plasma IL-6 concentration is inversely related to insulin sensitivity, and acute-phase proteins associate with glucose and lipid metabolism in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Does autonomic function link social position to coronary risk? The Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Tumor necrosis factor alpha: a key component of the obesity-diabetes link

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Reactive oxygen species have a causal role in multiple forms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Burst-like control of lipolysis by the sympathetic nervous system in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Echocardiographic Epicardial Adipose Tissue Is Related to Anthropometric and Clinical Parameters of Metabolic Syndrome: A New Indicator of Cardiovascular Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Role of hepatic STAT3 in brain-insulin action on hepatic glucose production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Augmentation of 11beta-hydroxysteroid dehydrogenase type 1 in LPS-activated J774.1 macrophages--role of 11beta-HSD1 in pro-inflammatory properties in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Retinol-binding protein 4 in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

The influence of physical activity on abdominal fat: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Primacy of Hepatic Insulin Resistance in the Development of the Metabolic Syndrome Induced by an Isocaloric Moderate-Fat Diet in the Dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

PKC-theta knockout mice are protected from fat-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Obesity-associated improvements in metabolic profile through expansion of adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Role of mitochondrial dysfunction in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Emerging roles of apelin in biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Reversal of obesity by targeted ablation of adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

(Peri)vascular production and action of pro-inflammatory cytokines in brain pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Selective parasympathetic innervation of subcutaneous and intra-abdominal fat--functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-alpha signaling protected Wistar rats from diet-induced obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Plasminogen activator inhibitor-1 modulates adipocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Pleiotropic functions of plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Adiponectin and development of type 2 diabetes in the Pima Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

A transgenic model of visceral obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

The regulation of total body fat: lessons learned from lipectomy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Human epicardial adipose tissue is a source of inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Sirtuins in mammals: insights into their biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Hypothalamic resistin induces hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Inflamed fat: what starts the fire?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Splanchnic lipolysis in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Ventromedial Hypothalamic Lesions and the Mobilization of Fatty Acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Central administration of oleic acid inhibits glucose production and food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Hypothalamic insulin signaling is required for inhibition of glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Mitochondrial dysfunction in the elderly: possible role in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

A brain-liver circuit regulates glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Local activation of the IkappaK-NF-kappaB pathway in muscle does not cause insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Hemodynamic actions of insulin in rat skeletal muscle: evidence for capillary recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Resistin is an inflammatory marker of atherosclerosis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

21 January 2018

Magic bullets melt fat.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Mechanism of free fatty acid-induced insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

The metabolically obese, normal-weight individual revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Metabolic syndrome: adenosine monophosphate-activated protein kinase and malonyl coenzyme A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Adipose tissue mass can be regulated through the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Monocyte chemoattractant protein 1 in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Insulin sensitivity: modulation by nutrients and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Adipose tissue: from lipid storage compartment to endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Monitoring of stored and available fuel by the CNS: implications for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Leptin effects on pancreatic beta-cell gene expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

TLR4 links innate immunity and fatty acid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Alterations of insulin sensitivity by the implantation of 3T3-L1 cells in nude mice. A role for TNF-alpha?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Vascular function, insulin resistance and fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Body fatness and fat distribution as predictors of metabolic abnormalities and early carotid atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

RBP4, an unexpected adipokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

21 January 2018

The inflammatory reflex

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Resistin: a new link between obesity and insulin resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Modulation of angiogenesis during adipose tissue development in murine models of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Inflammation, stress, and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Adipokine gene expression in brain and pituitary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Regulation of hypothalamic malonyl-CoA by central glucose and leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Adiponectin suppresses IkappaB kinase activation induced by tumor necrosis factor-alpha or high glucose in endothelial cells: role of cAMP and AMP kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Epidemiologic and economic consequences of the global epidemics of obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Adiposity and hyperinsulinemia in Indians are present at birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Insulin transport across capillaries is rate limiting for insulin action in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Insulin-induced vasodilatation: physiology or pharmacology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Serum vaspin concentrations in human obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Insulin sensitivity of muscle capillary recruitment in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Effects of Chronic Rosiglitazone Therapy on Gene Expression in Human Adipose Tissuein Vivoin Patients with Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Plasma Osteopontin Levels and Expression in Adipose Tissue Are Increased in Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Increased Inflammatory Properties of Adipose Tissue Macrophages Recruited During Diet-Induced Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2009

10.1152/AJPENDO.00015.2009

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference